Month: August 2017


Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs

Synthace Ltd., the technology company behind the Antha operating system for biology has announced that it has raised £7.3m ($9.6m) in Series A funding.

Read more

Synthace collaborates with Oxford BioMedica, Cell and Gene Therapy Catapult and Stratophase

A £2 million two-year collaboration is to explore a next-generation gene and cell therapy manufacturing platform for clinical and commercial applications.

Read more

Cambridge Consultants and Synthace launch new partnership

Product design and development firm Cambridge Consultants have joined forces with Synthace in an ambitious bid to unlock the full potential of biology.

Read more